BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 8913364)

  • 1. Identification of competitive antagonists of the P2Y1 receptor.
    Boyer JL; Romero-Avila T; Schachter JB; Harden TK
    Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
    Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK
    Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
    Filtz TM; Li Q; Boyer JL; Nicholas RA; Harden TK
    Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
    Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
    Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.
    Nicholas RA; Watt WC; Lazarowski ER; Li Q; Harden K
    Mol Pharmacol; 1996 Aug; 50(2):224-9. PubMed ID: 8700127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
    Schachter JB; Harden TK
    Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
    Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
    Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical stimulation releases nucleotides that activate P2Y1 receptors to trigger neural reflex chloride secretion in guinea pig distal colon.
    Cooke HJ; Xue J; Yu JG; Wunderlich J; Wang YZ; Guzman J; Javed N; Christofi FL
    J Comp Neurol; 2004 Jan; 469(1):1-15. PubMed ID: 14689470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
    Jin J; Daniel JL; Kunapuli SP
    J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
    Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
    Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
    Boyer JL; Lazarowski ER; Chen XH; Harden TK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.
    Kennedy C; Qi AD; Herold CL; Harden TK; Nicholas RA
    Mol Pharmacol; 2000 May; 57(5):926-31. PubMed ID: 10779375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7.
    Herold CL; Li Q; Schachter JB; Harden TK; Nicholas RA
    Biochem Biophys Res Commun; 1997 Jun; 235(3):717-21. PubMed ID: 9207227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different signal transduction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells.
    Lin WW; Chuang DM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):926-31. PubMed ID: 8014879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y1 receptor expression in Xenopus oocytes.
    O'Grady SM; Elmquist E; Filtz TM; Nicholas RA; Harden TK
    J Biol Chem; 1996 Nov; 271(46):29080-7. PubMed ID: 8910562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.
    Waldo GL; Harden TK
    Mol Pharmacol; 2004 Feb; 65(2):426-36. PubMed ID: 14742685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.